Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol
Open Access
- 1 June 2020
- journal article
- Published by F1000 Research Ltd in F1000Research
Abstract
Background: The process of translating preclinical findings into a clinical setting takes decades. Previous studies have suggested that only 5-10% of the most promising preclinical studies are successfully translated into viable clinical applications. The underlying determinants of this low success rate (e.g. poor experimental design, suboptimal animal models, poor reporting) have not been examined in an empirical manner. Our study aims to determine the contemporary success rate of preclinical-to-clinical translation, and subsequently determine if an association between preclinical study design and translational success/failure exists. Methods: Established systematic review methodology will be used with regards to the literature search, article screening and study selection process. Preclinical, basic science studies published in high impact basic science journals between 1995 and 2015 will be included. Included studies will focus on publicly available interventions with potential clinical promise. The primary outcome will be successful clinical translation of promising therapies - defined as the conduct of at least one Phase II trial (or greater) with a positive finding. A case-control study will then be performed to evaluate the association between elements of preclinical study design and reporting and the likelihood of successful translation. Discussion: This study will provide a comprehensive analysis of the therapeutic translation from the laboratory bench to the bedside. Importantly, any association between factors of study design and the success of translation will be identified. These findings may inform future research teams attempting preclinical-to-clinical translation. Results will be disseminated to identified knowledge users that fund/support preclinical research.Keywords
Funding Information
- Canadian Institutes of Health Research
This publication has 38 references indexed in Scilit:
- Blocking Macrophage Leukotriene B 4 Prevents Endothelial Injury and Reverses Pulmonary HypertensionScience Translational Medicine, 2013
- Threats to Validity in the Design and Conduct of Preclinical Efficacy Studies: A Systematic Review of Guidelines for In Vivo Animal ExperimentsPLoS Medicine, 2013
- One‐to‐many propensity score matching in cohort studiesPharmacoepidemiology and Drug Safety, 2012
- Raise standards for preclinical cancer researchNature, 2012
- Statistical Criteria for Selecting the Optimal Number of Untreated Subjects Matched to Each Treated Subject When Using Many-to-One Matching on the Propensity ScoreAmerican Journal of Epidemiology, 2010
- Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMedLaboratory Animals, 2010
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLoS Biology, 2010
- Empirical Evidence of Bias in the Design of Experimental Stroke StudiesStroke, 2008
- Drug administration in animal studies of cardiac arrest does not reflect human clinical experienceResuscitation, 2007
- Evolution and Translation of Research Findings: From Bench to WherePLoS Clinical Trials, 2006